Jacek Kubica
Overview
Explore the profile of Jacek Kubica including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
272
Citations
2275
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaminska H, Kurek K, Zembala M, Galwankar S, Tomaszewska M, Singh S, et al.
Cardiol J
. 2025 Mar;
PMID: 40062924
Background: Cardiac arrest in children is associated with high morbidity and mortality, primarily due to neurological injury. Biomarkers linked to brain injury, released into circulation from compromised elements of the...
2.
Pruc M, Swieczkowski D, Cander B, Jaguszewski M, Galwankar S, Di Somma S, et al.
Cardiol J
. 2025 Feb;
PMID: 39976389
Background: The role of Cystatin C (CysC) in the diagnosis and prognosis of cardiovascular disease, particularly acute coronary syndrome (ACS), is increasingly significant. The goal of this meta-analysis was to...
3.
Tajstra M, Wilczek K, Witkowski A, Wita K, Stepinska J, Wojakowski W, et al.
Kardiol Pol
. 2025 Jan;
PMID: 39835678
No abstract available.
4.
Kubica J, Adamski P, Gajda R, Kubica A, Ostrowska M, Casu G, et al.
Cardiol J
. 2025 Jan;
32(1):83-89.
PMID: 39776051
According to the ESC guidelines, cangrelor may be considered in P2Y12-inhibitor-naïve acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). The aim of this review is to summarize available...
5.
Kupisz-Urbanska M, Jankowski P, Ceglowska U, Teisseyre P, Buszman P, Danilowicz-Szymanowicz L, et al.
Kardiol Pol
. 2025 Jan;
83(2):149-156.
PMID: 39743906
Background: Myocardial infarction (MI) remains the leading cause of death, especially in the elderly. Aims: To characterize management and factors related to event-free survival in patients with acute MI aged...
6.
Bergmann K, Stefanska A, Kubica J, Krintus M, Panteghini M
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685587
Low but detectable cardiac troponin (cTn) concentrations may reflect cardiovascular (CV) risk in a primary prevention setting. Using previously described thresholds for CV risk stratification, we assessed the influence of...
7.
Kubica J, Adamski P, Ostrowska M, Kubica A, Gajda R, Badariene J, et al.
Int J Cardiol
. 2024 Dec;
421():132897.
PMID: 39647786
De-escalation of dual antiplatelet (DAPT) intensity may be considered in patients with high risk of bleeding after acute coronary syndrome. Some high risk patients after de-escalation may require antithrombotic therapy...
8.
De Filippo O, Wanha W, Sanavia T, Januszek R, Giacobbe F, Campo G, et al.
EuroIntervention
. 2024 Nov;
20(21):e1340-e1354.
PMID: 39492702
Background: Limited data exist on ultrathin-strut drug-eluting stent (ultrathin DES) performance in DES in-stent restenosis (ISR). Aims: We aimed to assess the efficacy and safety of ultrathin DES compared to...
9.
Ostrowska M, Kasprzak M, Fabiszak T, Gajda J, Jaje-Rykowska N, Michalski P, et al.
PLoS One
. 2024 Oct;
19(10):e0309922.
PMID: 39436870
Background: Patients hospitalized due to Coronavirus disease 2019 (COVID-19) are still burdened with high risk of death. The aim of this study was to create a risk score predicting in-hospital...
10.
Motovska Z, Hlinomaz O, Mrozek J, Kala P, Geisler T, Hromadka M, et al.
EuroIntervention
. 2024 Oct;
20(20):e1309-e1318.
PMID: 39432252
Cardiogenic shock (CS) is a devastating and fatal complication of acute myocardial infarction (AMI). CS can affect the pharmacokinetics and pharmacodynamics of medications. The unique properties of cangrelor make it...